WallStreetZenWallStreetZen

NASDAQ: TERN
Terns Pharmaceuticals Inc Stock

$5.13-0.04 (-0.77%)
Updated Sep 25, 2023
TERN Price
$5.13
Fair Value Price
N/A
Market Cap
$313.30M
52 Week Low
$4.38
52 Week High
$14.04
P/E
-4.38x
P/B
1.14x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$72.07M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.06
Operating Cash Flow
-$52M
Beta
0.79
Next Earnings
Nov 7, 2023
Ex-Dividend
N/A
Next Dividend
N/A

TERN Overview

Terns Pharmaceuticals Incorporated is a clinical-stage biopharmaceutical company developing small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, andTERN-201, a vascular adhesion protein-1 inhibitor, are in clinical trials for the treatment of NASH. Terns Pharmaceuticals was incorporated in 2016 and is headquartered in Foster City, CA.

Zen Score

Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how TERN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

TERN is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
TERN is good value based on its book value relative to its share price (1.14x), compared to the US Biotechnology industry average (5.09x)
P/B vs Industry Valuation
TERN is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more TERN due diligence checks available for Premium users.

Be the first to know about important TERN news, forecast changes, insider trades & much more!

TERN News

Valuation

TERN price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-4.38x
Industry
12.93x
Market
14.28x

TERN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.14x
Industry
5.09x
TERN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

TERN's financial health

Profit margin

Revenue
$0.0
Net Income
-$17.9M
Profit Margin
0%
TERN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$289.7M
Liabilities
$15.5M
Debt to equity
0.06
TERN's short-term assets ($288.32M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TERN's short-term assets ($288.32M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TERN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$13.0M
Investing
-$90.8M
Financing
$489.0k
TERN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

TERN vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
TERN$313.30M-0.77%-4.38x1.14x
MCRB$308.97M-7.66%-1.94x13.66x
ABUS$318.36M-1.55%-4.13x2.36x
NUVB$306.52M+5.26%-3.50x0.49x
ERAS$320.21M-5.78%-1.17x0.88x

Terns Pharmaceuticals Stock FAQ

What is Terns Pharmaceuticals's quote symbol?

(NASDAQ: TERN) Terns Pharmaceuticals trades on the NASDAQ under the ticker symbol TERN. Terns Pharmaceuticals stock quotes can also be displayed as NASDAQ: TERN.

If you're new to stock investing, here's how to buy Terns Pharmaceuticals stock.

What is the 52 week high and low for Terns Pharmaceuticals (NASDAQ: TERN)?

(NASDAQ: TERN) Terns Pharmaceuticals's 52-week high was $14.04, and its 52-week low was $4.38. It is currently -63.47% from its 52-week high and 17.12% from its 52-week low.

How much is Terns Pharmaceuticals stock worth today?

(NASDAQ: TERN) Terns Pharmaceuticals currently has 61,071,897 outstanding shares. With Terns Pharmaceuticals stock trading at $5.13 per share, the total value of Terns Pharmaceuticals stock (market capitalization) is $313.30M.

Terns Pharmaceuticals stock was originally listed at a price of $19.79 in Feb 8, 2021. If you had invested in Terns Pharmaceuticals stock at $19.79, your return over the last 2 years would have been -74.08%, for an annualized return of -49.09% (not including any dividends or dividend reinvestments).

How much is Terns Pharmaceuticals's stock price per share?

(NASDAQ: TERN) Terns Pharmaceuticals stock price per share is $5.13 today (as of Sep 25, 2023).

What is Terns Pharmaceuticals's Market Cap?

(NASDAQ: TERN) Terns Pharmaceuticals's market cap is $313.30M, as of Sep 26, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Terns Pharmaceuticals's market cap is calculated by multiplying TERN's current stock price of $5.13 by TERN's total outstanding shares of 61,071,897.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.